Tissue Selection for Microscopic Evaluation

1. Guiding Principles of Section Selection

After you have methodically sectioned the thyroid and laid out the slices, the primary goals of section selection are to submit tissue that will allow you to:

• Establish the definitive diagnosis of any lesion(s).
• Assess for features of malignancy, particularly capsular and vascular invasion in encapsulated nodules.
• Document all necessary staging parameters, such as tumor size, extension to the capsule or beyond, and the status of surgical margins.
• Evaluate the non-lesional thyroid parenchyma for any concurrent pathology (e.g., thyroiditis, C-cell hyperplasia).

Let's begin with a practical demonstration that covers the core concepts.

As the video highlights, your sampling strategy is dictated primarily by the gross appearance of the nodule, especially its size and whether it appears encapsulated or infiltrative.

2. Sampling Strategy: Encapsulated vs. Infiltrative Nodules

The distinction between a well-circumscribed, encapsulated nodule and an ill-defined, infiltrative one is the most critical factor guiding your sampling strategy.

Encapsulated Nodules

These are common and represent the spectrum of follicular-patterned lesions, from benign follicular adenomas to follicular carcinomas and NIFTP. For these tumors, the diagnosis of malignancy is based almost entirely on identifying capsular or vascular invasion. Therefore, your sampling priority is the interface between the nodule and the adjacent thyroid tissue.

• Rule: The entire capsule of the nodule must be submitted for histologic examination.
• For smaller nodules (≤ 2 cm): This is straightforward—submit the entire nodule.
• For larger nodules (> 2 cm): The principle remains the same, but you can be more selective. Submit serial, perpendicular sections of the entire tumor capsule, but you may omit the central, fleshy parts of the tumor if it appears uniform.

Infiltrative Nodules

These nodules, which often correspond to classic papillary thyroid carcinoma (PTC), lack a well-defined capsule. Their borders are irregular and blend into the surrounding parenchyma.

• Rule: The sampling priority is to demonstrate the infiltrative nature of the lesion and its relationship to surgical margins and any extrathyroidal structures (like skeletal muscle).
• For smaller nodules (e.g., ≤ 2 cm): Submit the entire lesion to document its full size and extent.
• For larger nodules (> 2 cm): Submit representative sections at a frequency of at least one section per centimeter of the greatest dimension. Crucially, these sections should include the advancing edge of the tumor and its closest approach to any inked margins.

3. A Framework for Cassette Submission

To solidify these concepts, let's review some published guidelines that provide a clear, systematic framework for section submission in various clinical scenarios.

These guidelines reinforce our key principles. Additionally, they provide direction for other common scenarios:

• Multinodular Goiter: Sample approximately one cassette per centimeter of the gland's greatest dimension, focusing on any areas that appear grossly suspicious (e.g., solid, white, firm, hemorrhagic, or distinctly different from the other nodules).
• Diffuse Processes (e.g., Graves' disease, Hashimoto's thyroiditis): If no dominant nodule is present, submit 2-3 representative sections from each lobe and one from the isthmus to document the diffuse process. The UCLA guidelines suggest "3 blocks per lobe (upper, mid, lower) and isthmus."

4. Sampling Margins and Background Parenchyma

Beyond the main lesion, submitting sections of the margins and the "normal" thyroid is essential.

• Surgical Margins: For a hemithyroidectomy, the key surgical margin is the isthmic margin. You should submit a perpendicular section showing the thyroid parenchyma up to the inked margin. For any lesion, you must submit sections demonstrating its closest approach to the inked capsular surfaces (anterior and posterior).
• Background Parenchyma: Always submit at least two representative sections of thyroid tissue that appears grossly uninvolved. This is critical for identifying background pathology like Hashimoto's thyroiditis, which has prognostic implications, or C-cell hyperplasia in cases suspicious for medullary carcinoma.

5. Advanced Topic: Integrating Pre-operative Data into Your Strategy

As you work to upgrade your skills, it's important to connect gross pathology with clinical and molecular data. Information from the fine-needle aspiration (FNA) report can—and should—refine your sampling approach.

To summarize this advanced concept:

• If the FNA is "Suspicious for PTC" (a BRAF-like tumor is likely), you anticipate an infiltrative lesion. Your sampling is focused on documenting size and demonstrating invasion into adjacent structures or margins.
• If the FNA shows "Atypia" or "Follicular Neoplasm" (a RAS-like tumor is possible), you anticipate an encapsulated lesion. Your sampling must be exhaustive at the capsule to rule in or rule out invasion, as this is the primary determinant of malignancy.

Finally, a practical tip from the Weill Cornell video (LINK, section 6): ensure you don't overfill your cassettes. Two or three thin (3 mm) tissue slices per cassette is ideal. Overcrowding prevents proper fixation and processing, leading to poor-quality slides that can compromise diagnosis.

Conclusion

In this lesson, we have detailed the strategic process of selecting representative sections for microscopic analysis. By understanding the "why" behind the rules, you can confidently and efficiently sample any thyroidectomy specimen.

Key Takeaways:

• Section selection is guided by the need to establish a diagnosis, assess for invasion, and determine stage.
• The sampling strategy is fundamentally different for encapsulated lesions (submit the entire capsule to find invasion) versus infiltrative lesions (demonstrate extent and relationship to margins).
• Use size-based rules as a guide: submit nodules ≤ 2 cm entirely; for larger nodules, submit at least one section per centimeter, focusing on the most important areas.
• Always submit representative sections of surgical margins (e.g., isthmus) and grossly unremarkable thyroid parenchyma.
• Leverage pre-operative FNA and molecular data to anticipate the lesion type and tailor your sampling strategy accordingly.

In our next lesson, we will focus on documenting your gross findings relevant to staging. Now that you know how to dissect and sample the specimen, we will cover how to translate your observations into a clear, concise gross description that includes all the essential elements for the CAP synoptic report and AJCC staging.